BACK
LEARNING OBJECTIVES
After completing this learning activity, participants will be better able to:
March 30, 2026
7:00 pm -
5:00 pm -
4:00 pm -
5:00 pm -
4:00 pm -
8:00 pm EST
6:00 pm MST
5:00 pm PST
6:00 pm MST
5:00 pm PST
After completing this learning activity, participants will be better able to:
- Examine the inflammatory and immune–metabolic interface linking CKM syndrome and PCKD progression
- Analyze how obesity, diet, and physical inactivity shape cyst growth and CKD trajectory
- Integrate emerging CKM-directed therapies (SGLT2i, GLP-1 RA, hydration strategies) into advanced PCKD management
Louis Girard, MD, MBT, FRCPC
Nephrologist and Clinical Associate Professor
Medical Director of Glomerulonephritis
Medical Director of Apheresis
Department of Medicine, Division of Nephrology
Cumming School of Medicine
University of Calgary
Calgary, AB
Medical Director of Glomerulonephritis
Medical Director of Apheresis
Department of Medicine, Division of Nephrology
Cumming School of Medicine
University of Calgary
Calgary, AB
Louise Moist, MD, MSc, CCPE
Professor of Medicine and Epidemiology
Deputy Chair, Division of Nephrology
Site Chief, Nephrology Victoria Hospital
Schulich School of Medicine and Dentistry,
Western University
London, ON
Deputy Chair, Division of Nephrology
Site Chief, Nephrology Victoria Hospital
Schulich School of Medicine and Dentistry,
Western University
London, ON